John Green posted a video about a week ago calling out Johnson & Johnson for extending their patent for Bedaquiline, a medication that treats multi-drug-resistant tuberculosis. The extension would prevent inexpensive generic versions from entering countries that are being ravaged by TB. After the video received critical reception and with John’s call to action, the public pounced on J&J. This led to J&J announcing they would allow the generic versions of Bedaquiline to be produced and shipped to the majority of low- and middle-income countries hit hard by TB, including countries where the patent is still in effect. We still don’t know which specific countries those are, but it’s still great news!
Plus, Hank Green is done with his chemo and seems to be mostly cancer-free for the time being.
John Green posted a video about a week ago calling out Johnson & Johnson for extending their patent for Bedaquiline, a medication that treats multi-drug-resistant tuberculosis. The extension would prevent inexpensive generic versions from entering countries that are being ravaged by TB. After the video received critical reception and with John’s call to action, the public pounced on J&J. This led to J&J announcing they would allow the generic versions of Bedaquiline to be produced and shipped to the majority of low- and middle-income countries hit hard by TB, including countries where the patent is still in effect. We still don’t know which specific countries those are, but it’s still great news!
Plus, Hank Green is done with his chemo and seems to be mostly cancer-free for the time being.